A resolution expressing support for the designation of November 2022 as "National Alpha-1 Antitrypsin Deficiency Awareness Month".
Active· Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4973)
Introduced
Sep 22, 22
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending
Introduced
Sep 22, 22
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending
Executive Summary
This resolution supports the designation of November 2022 as National Alpha-1 Antitrypsin Deficiency Awareness Month. Alpha-1 antitrypsin deficiency is a genetic disease that increases the risk of harm to the lungs, liver, skin, and blood vessels.
Action Timeline
2
SEP 22, 2022•IntroReferral
Introduced in Senate
SEP 22, 2022•IntroReferral
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4973)